Istituto Scientifico Romagnolo per Studio e Cura Tumori IRST

Meldola 47014

0 studies enrolling now · 1 studies all time

What they study most

UC (Urothelial Cancer)

Studies at this site

• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed